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Detectable splicing by the Saccharomyces cerevisiae mitochondrial
bI3 group I intron RNA in vitro is shown to require both an
intron-encoded protein, the bI3 maturase, and the nuclear-
encoded protein, Mrs1. Both proteins bind independently to the
bI3 RNA. The bI3 maturase binds as a monomer, whereas Mrs1 is
a dimer in solution that assembles as two dimers, cooperatively, on
the RNA. The active six-subunit complex has a molecular mass of
420 kDa, splices with a kcat of 0.3 min1, and binds the guanosine
nucleophile with an affinity comparable to other group I introns.
The functional bI3 maturase domain is translated from within the
RNA that encodes the intron, has evolved a high-affinity RNA-
binding activity, and is a member of the LAGLIDADG family of DNA
endonucleases, but appears to have lost DNA cleavage activity.
Mrs1 is a divergent member of the RNase H fold superfamily of
dimeric DNA junction-resolving enzymes that also appears to have
lost its nuclease activity and now functions as a tetramer in RNA
binding. Thus, the bI3 ribonucleoprotein is the product of a process
in which a once-catalytically active RNA now obligatorily requires
two facilitating protein cofactors, both of which are compromised
in their original functions.
Many small ribozymes, both those that occur naturally (1)and those that are products of in vitro selection experi-
ments (2), display an impressive array of catalytic activities.
Although these simple structures are capable of performing
catalysis, most cellular ribozymes have undergone a process of
elaboration in which potentially simple RNA active sites are
bolstered by additional RNA structural domains (3, 4) or protein
cofactors (5–9).
One example of this process is the group I introns. The group
I intron RNA core consists of two extended and roughly
coaxially stacked helices that form a catalytic cleft, which binds,
in turn, the 5 and 3 splice site helices and the guanosine
cofactor (guanosine 5-monophosphate, pG) (4, 5, 10). Although
the catalytic core is relatively compact and can independently
form a functional active site (11), most group I introns have
acquired additional peripheral structures that function to stabi-
lize the RNA core (4, 12, 13). Moreover, whereas a large number
of group I introns have been identified by sequence and struc-
tural analysis (4, 14), both anecdotal and experimental evidence
suggests that many have lost their self-splicing activity (15). It
appears that group I intron RNAs commonly recruit protein
cofactors and now function as obligatory ribonucleoproteins
(8, 16).
The Saccharomyces cerevisiae mitochondrial cytochrome b bI3
group I intron represents an especially intriguing case of elab-
oration by accretion of peripheral RNA domains and protein
cofactors. First, the bI3 RNA potentially spans two group I
intron subgroups, IA2 and IB4, characterized by RNA sequence
insertions between helices P7 and P3 and adjacent to P9 and by
an extension of the P5 helix, respectively (4) (Fig. 1A, boxed
structures). The bI3 intron also contains two tertiary interactions
common to many catalytic RNAs, the L2-P8 and L9-P5 tetra-
loop–minor groove receptor motifs (4, 17, 18) (Fig. 1A, dashed
lines).
Second, genetic evidence indicates that at least two genes are
required for bI3 RNA splicing in vivo. The first encodes the bI3
maturase, most of whose coding sequence is inserted within a
peripheral domain of the intron, in L8 (Fig. 1 A) and is translated
in frame with the native cytochrome b B3 exon (19) (Fig. 1B).
The maturase is a member of a large family of DNA endonucle-
ases identifiable, in part, by conserved LAGLIDADG motifs
(20). The presence of the bI3 maturase ORF within the intron
probably represents an early colonization event by a LAGLI-
DADG DNA endonuclease precursor (21–24). The RNA-
directed maturase, or splicing facilitation, activity is likely a
subsequent innovation. Because the bI3 maturase coding se-
quence lies within the intron, this function is potentially linked
with evolution of the intron RNA.
The second gene is MRS1 (25, 26), whose protein product is
encoded in the nucleus, targeted to the mitochondria, and
homologous with the nuclear-encoded mitochondrial DNA-
resolving enzyme, Cce1 (27, 28). Cce1 recognizes, manipulates,
and cleaves four-way DNA junctions (27) and is a member of the
RNase H fold family of DNA junction-resolving enzymes (29,
30). Mrs1 is highly diverged from the RNase H fold superfamily
and lacks several residues implicated in DNA cleavage.
In this work, we find that detectable in vitro splicing by the bI3
intron has become wholly dependent on both the intron-encoded
bI3 maturase and the co-opted Mrs1 proteins. The bI3 maturase
and Mrs1 bind the intron independently and assemble to form an
active ribonucleoprotein catalyst of 420 kDa. Both splicing
cofactor proteins have evolved such that they appear to have
compromised the original endonuclease activities of their struc-
tural homologs.
Experimental Procedures
The bI3 Maturase, Mrs1, and bI3 RNA. To circumvent extensive
codon misrepresentation, an Escherichia coli expression con-
struct for the mitochondrial bI3 maturase gene [strain 777–3A
(19)] was cloned by total gene synthesis by using recursive PCR
(31). The native mRNA encodes a strongly hydrophobic N-
terminal peptide of 100 amino acids [http:www.cbs.dtu.dk
servicesTMHMM-2.0 (32)], derived from both 5-exon and
intron (75 amino acids) sequences. Therefore, a gene for the
conserved soluble maturase domain (850 bp, 272 amino acids,
starting at the sequence MNNTI) was synthesized from 12
overlapping 120-nt oligos and two 25-nt amplification oligos in
a two-step PCR reaction (pfu turbo, Stratagene) (Fig. 1B). The
MRS1-coding sequence was generated by PCR from total yeast
genomic DNA (strain DBY746). Coding sequences were con-
firmed by sequencing and expressed as N-terminal (His)10
fusions (pET19b, Novagen) in E. coli BL21(DE3)pLysS or
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BL21(DE3) cells, respectively. Pelleted cells from 1 L cultures
were resuspended in 25 ml of either Mrs1 prep buffer [40 mM
Hepes (pH 7.5)650 mM NaCl5 mM 2-mercaptoethanol10%
(volvol) glycerol] or maturase prep buffer [20 mM phosphate
buffer (pH 8.0)900 mM NaCl5 mM 2-mercaptoethanol10%
(volvol) glycerol]. Cells were sonicated, and the lysate was
cleared by centrifugation at 35,000 rpm (Beckman 60 Ti rotor)
and mixed with 1.5 ml of Ni2-NTA agarose slurry (Qiagen,
Chatsworth, CA). Maturase-bound resin was washed twice with
10 ml of maturase prep buffer plus 2 mM imidazole (pH 8.0),
then both proteins were washed with Mrs1 prep buffer with up
to 60 mM imidazole (pH 8.0). Proteins were eluted in 5 ml of 40
mM Hepes (pH 7.5), 600 mM NaCl, 5 mM 2-mercaptoethanol,
20% (volvol) glycerol, and 250 mM imidazole (pH 8.0). Eluted
fractions were dialyzed against 40 mM Hepes (pH 7.5), 400 mM
NaCl, 5 mM DTT, and 50% (volvol) glycerol and stored at
20°C. Both proteins were judged greater than 95% homoge-
nous by SDSPAGE analysis and Coomassie blue staining.
Protein concentrations were determined by UV spectroscopy
(33). Mrs1 concentrations are reported in terms of the solution
dimer, unless stated otherwise.
Intron precursor sequences for the native and L8 constructs
(15) were cloned into pTZ18U, and RNAs were generated by
runoff transcription using T7 polymerase from HindIII-digested
plasmid DNA (34). The bI3 RNA precursor spanned 10 nt of
vector sequence, the entire 75-nt 5-exon, the 1,752-nt intron,
and 31 nt of the 3-exon. Most experiments were performed with
the bI3-L8 construct (designed by R. Waring and coworkers),
in which the 1,325-nt L8 loop is replaced by 6 nt (Fig. 2C).
bI3 RNA Splicing and Protein Binding. Quantitative RNA splicing
reactions (20–25 l) were performed by using 1 nM 5-32P-
end-labeled RNA, 5 nM bI3 maturase, and 10 nM Mrs1 dimer.
Mrs1 binding is coupled with maturase binding such that the K1/2
for binding is 2 nM in the presence of maturase. Thus, both
Mrs1 and maturase were saturating in the splicing experiments
reported here (Figs. 2 and 3A). Precursor RNA was incubated at
90°C for 1 min, placed on ice, and refolded at 36°C for 10 min
in reaction buffer [40 mM Hepes (pH 7.5)80 mM KOAc (pH
7.4)20 mM MgCl21 mM DTT10 g/ml of BSA]. Proteins
were added simultaneously and allowed to bind for 30 min at
36°C; control experiments showed that RNA splicing is not
affected by longer preincubation times or by order of protein
addition. Reactions were initiated by addition of pG to a final
concentration of 3 mM, resolved by denaturing 8% polyacryl-
amide gels, and quantified with a PhosphorImager (Molecular
Dynamics). Reaction rates were determined by a nonlinear
least-squares fit: fraction precursor RNA  fekt  (1  f ),
where k is the observed rate constant, and f is the fraction
reactive RNA (typically 65–70%). For high-sensitivity splicing
reactions (35), bI3 RNA concentrations were 50 nM, proteins
were added in excess, and splicing was initiated by addition of
[32P]-GTP (3,000 Cimmol) to 0.3 M.
RNA-binding assays were performed by filter partitioning
(34) and preincubating membranes in 40 mM Hepes (pH 7.5)
and 80 mM KOAc (pH 7.4) for 30 min. Maturase and Mrs1
binding measurements contained 0.2 pM and 10 pM bI3-L8
RNA, respectively, with the [BSA] supplemented to 30 gml.
Membranes were washed with reaction buffer before and after
filtering, dried, and quantified. Maturase-binding experiments
were analyzed by using a one-site binding model: fraction RNA
bound  A ([P][P]  KD), where A is the total fraction bound
RNA, [P] is the free protein concentration, and KD is the
equilibrium dissociation constant. Mrs1 binding curves were
analyzed by using fraction RNA bound  A ([P]n[P]n  K1/2n),
where n is the apparent Hill coefficient, and K1/2 is the [Mrs1]
where one-half of the RNA is bound.
Sedimentation Equilibrium Analysis. Experiments (XLA analytical
ultracentrifuge; Beckman), were performed at 4°C until equi-
librium was established (typically 16 h). Samples were analyzed
in reaction buffer at 10 mM Mg2 and substituting 5 mM
2-mercaptoethanol for DTT to achieve low absorbance offsets.
Protein molecular weights were determined at 2, 4, and 8 M at
7,000 and 10,000 rpm (detection at 280 nm); observed molecular
masses were identical, within error. For RNA–protein com-
plexes, 70 nM bI3-L8 RNA was bound with (i) 420 nM Mrs1,
(ii) 580 nM Mrs1, (iii) 100 nM bI3 maturase, or (iv) 360 nM Mrs1
and 100 nM bI3 maturase and spun at 5,000 and 6,500 rpm
(detection at 260 nm). Meniscus depletion runs (45,000 rpm, 5 h)
established sample background. Offsets were 0.05 or less and
were corrected accordingly. Sedimentation profiles (absorbance
as a function of radius) were fit (Origin XLA software, Beck-
man) to a version of the Lamm equation (equation 2 in ref. 36),
assuming a single ideal species, a good assumption given the
observed tight binding constants (Fig. 3), and calculating partial
specific volumes from the weighted average of the RNA (0.537
gcm3) and protein (0.730 gcm3) components; solution density
() was 1.008.
Maturase Endonuclease and MRS1 Junction-Resolving Assays. DNA
endonuclease assays (16, 23) contained 50 mM Hepes (pH 7.5),
Fig. 1. Organization of the bI3 group I intron. (A) Secondary structure of the
bI3 RNA (4). 5 and 3 splice sites are marked with arrows. Peripheral domains
are boxed, the guanosine cofactor-binding site is in black, and the L2-P8 and
L9-P5 interactions are shown with dashed lines. Px identifies base paired
helices. (B) The bI3 maturase RNA is translated in frame with the cyt b B3 exon
to yield the bI3 maturase protein, consisting of hydrophobic (potentially
membrane bound) and maturase domains. The LAGLIDADG motifs, P1 and
P2, reside within the ‘‘soluble’’ portion of the protein, for which a synthetic
gene was constructed.








80 mM KOAc, 1 mM DTT, 5 gml of BSA, and 0, 10, or 50 mM
MgCl2, or 10 or 50 mM MnCl2 at 37°C using 20 nM–2 M
maturase. Double-stranded DNA substrates were made from
63-nt complementary strands containing 45 nt of exon–exon
junction sequence at their center; sense strand  5-ccgga attct
tgtat cttga ttatg aggtg ggttc tcagt atcta accct ctaag gatcc gcg-3
(exon junction indicated with a ). Control duplexes contained
19 altered base pairs at the exon–exon junction. Strands were
individually 5-32P-end-labeled, purified by denaturing electro-
phoresis, and annealed with a 1.5-fold excess of unlabeled
complementary strand. Native gel electrophoresis confirmed
that the radiolabeled strands annealed quantitatively to form
duplexes. Synthetic 10-, 32-, and 51-mer oligodeoxynucleotides
were used as markers for cleavage products. DNA junction-
resolving assays with Mrs1 were performed exactly as described
(ref. 27; by using the branch migrating junction jmb3 and the
fixed junction 1).
Results
bI3 Intron Splicing Requires Both Mrs1 and bI3 Maturase Proteins. The
first step in group I intron splicing involves attack of the
3-hydroxyl of a guanosine nucleophile at the 5 end of the intron
to cleave the exon–intron junction. In the second step, the new
free 3-OH from the 5-exon attacks the 3 splice site to yield
ligated exons and the G-intron product (5). We monitored
splicing of the bI3 group I intron by using two approaches.
Reaction kinetics are most accurately followed using a 5-32P-
end-labeled RNA precursor and a pG nucleophile. To observe
potentially inefficient self-splicing reactions, we also followed
splicing by using the sensitive approach (35) of detecting addition
of [32P]-GTP to unlabeled RNA.
In the absence of protein cofactors, splicing by both the native
and bI3-L8 introns is undetectable. Addition of either Mrs1 or
bI3 maturase proteins alone at concentrations from 5 to 500 nM
and in the presence of up to 25 mM MgCl2 also yielded no
detectable splicing products, as judged by both radiolabeled
intron (Fig. 2 A) or [32P]-GTP addition assays. However, assem-
bly of the quaternary complex consisting of the bI3 intron RNA,
Mrs1, the bI3 maturase, and pG results in efficient splicing and
near quantitative conversion of all RNAs that undergo 5 splice
site cleavage into the ligated exon product (Fig. 2 A). Formation
of the ligated exon product occurred at the same rate as reaction
of the RNA precursor, indicating that guanosine attack at the 5
splice site is limiting for the overall two-step splicing reaction.
Using excess protein and saturating pG, we compared splicing
reactions for the native intron with that of a simplified intron in
which the 1,325-nt loop in L8 is deleted (Figs. 1 A, 2 B and C).
The bI3-L8 RNA spliced at a rate of 0.29 min1 and, signifi-
cantly, over 65% of the RNA reacts over 30 min. The native bI3
intron splices at a rate of 0.16 min1 and less than 20% of the RNA
reacts over this period (Fig. 2B). The difference in reactive fractions
for the native and simplified RNAs probably reflects a greater
extent of misfolding in the much larger native RNA.
Splicing by the RNA alone at [Mg2] up to 100 mM was
undetectable by the sensitive guanosine addition assay (data not
shown); we estimate that these reactions must be slower than
0.00002 min1 to avoid detection. Thus, addition of both Mrs1
and the bI3 maturase yields a 104-fold, or greater, rate enhance-
ment over self-splicing or splicing by incompletely formed
complexes.
We determined the Michaelis–Menten constant (KM) for the
interaction of the pG substrate with the bI3 ribonucleoprotein
ternary complex by following the rate of splicing as a function of
[pG]. The KM
pG for the bI3 intron was 180  20 M (Fig. 3A, open
circles). KM is given by (kpG
off  kcatkpG
on ), making the reasonable
assumption that there are no hidden intermediates for associa-
tion of this substrate with the preformed ternary complex. If kcat
is slow relative to pG dissociation (kpG
off), then KM would reflect
equilibrium binding by pG (34, 37).
We determined KM
pG at pH 6.5, which decreased the observed
kcat by 6- to 10-fold (Fig. 3A and data not shown), and found the
KM to be equal to 210  60 M, identical, within error, to the
value at pH 7.5 (compare closed and open symbols in Fig. 3A).
Thus, slowing the chemical step after binding has no effect on
KM, supporting the assignment that the pG substrate binds the
bI3 holoribonucleoprotein with a KD of 0.2 mM.
The bI3 Maturase Assembles as a Monomer with the bI3 Group I Intron.
Sedimentation equilibrium analysis demonstrated that the bI3
maturase is a monomer in solution (Table 1). We determined the
equilibrium-binding constant for the maturase–RNA complex
by using a filter partitioning assay; the bI3 maturase binds very
tightly to the bI3 intron with a KD of 2.8 pM (Fig. 3B). We
established the ratio of maturase to RNA in the complex using
a stoichiometric binding assay in which the [RNA] was 100 nM,
or much greater than the KD (Fig. 3C). The inflection point
occurs at a proteinRNA ratio of 1.2  0.3, consistent with
formation of a bimolecular RNA–bI3 maturase complex.
Two Mrs1 Dimers Assemble Cooperatively with the bI3 Group I Intron.
The molecular mass of free Mrs1, determined by sedimentation
equilibrium, is 92  4 kDa, exactly twice the calculated mass of
a Mrs1 monomer (Table 1). Thus, we infer free Mrs1 is a dimer
in solution. Under conditions optimal for splicing (20 mM
Mg2), The Mrs1 dimer binds the bI3 intron in a strongly
cooperative manner. The Mrs1 dimer concentration required to
bind half of the RNA at equilibrium, the K1/2, is 11 nM, and the
apparent Hill coefficient is 2.0 (Fig. 3D; circles).
We observed marked differences in the mode of Mrs1 dimer
assembly as a function of [Mg2]. In the absence of Mg2, the
K1/2 is tighter at 0.12 nM and binding is distinctly noncooperative;
the apparent Hill coefficient is 1.0 (Fig. 3D; triangles). At the
intermediate Mg2 concentration of 4 mM, we observe transi-
tional behavior such that the K1/2 is 0.65 nM, and the apparent
Fig. 2. Reconstitution of an active bI3 ribonucleoprotein. (A) Detectable
splicing by the bI3 intron requires the presence () of both the bI3 maturase
and Mrs1. Reactions were monitored using a 5-32P-end-labeled bI3-L8 pre-
cursor and resolved by denaturing electrophoresis. Timepoints are 0, 2, 5, 10,
20, 30, and 45 min. (B) Comparative splicing by the native and bI3-L8 intron
RNAs, under conditions of saturating protein and pG. (C) Structure of the
bI3-L8 intron RNA. The 1,325-nt deletion lies in L8 and spans most of the ORF
encoding the bI3 maturase.
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Hill coefficient is 1.5 (Fig. 3D, diamonds). Cooperativity in Mrs1
dimer-binding plateaus by 8 mM Mg2, where the apparent Hill
coefficient is also 2.0 (data not shown). We determined the ratio
of Mrs1 to RNA in the complex using a stoichiometric binding
assay, where all added protein should bind quantitatively to the
RNA. The inflection point at 4.8  0.4 is approximately con-
sistent with binding by two Mrs1 dimers (four Mrs1 monomers
in total) at both 0 mM and 20 mM Mg2 (Fig. 3E; triangles and
circles, respectively).
Thus, there exist two Mrs1-binding sites on the bI3 RNA, each
of which binds one Mrs1 dimer. In the absence of Mg2, two
Mrs1 dimers bind independently; in contrast, under optimal
splicing conditions (20 mM Mg2), two Mrs1 dimers assemble on
the bI3 intron RNA through a strongly linked binding event.
The Functional bI3 Group I Intron Assembles to a 420-kDa Ribonucle-
oprotein. We monitored stepwise assembly of the bI3 ribonucle-
oprotein by using analytical ultracentrifugation. In sedimenta-
tion equilibrium experiments, the position of a molecule in the
centrifuge or complex is sensitive to the overall molecular mass
such that larger complexes achieve equilibrium at larger cell
radii. For tight binding stoichiometric complexes (Fig. 3), abso-
lute molecular masses can be obtained directly by global fitting
of the observed absorbance as a function of radial position (36).
The bI3-L8 RNA sediments with a molecular mass of 191  12
kDa (Fig. 4A; Table 1). This value is identical, within error, to the
calculated mass for this RNA, confirming that the RNA is a well
behaved monomer in these experiments. The bI3 maturase also
sediments as a monomer (see line 2 of Table 1). In contrast, Mrs1
sediments with a molecular mass of 92  4 kDa, exactly twice the
calculated mass (45 kDa) for the protein monomer. Thus, Mrs1, like
its homolog Cce1 (27, 38), is a solution dimer.
We could follow assembly of the bI3 holoribonucleoprotein
complex from its RNA, maturase, and Mrs1 components in a
straightforward way because protein absorbance is negligible
compared with RNA absorbance at 260 nm and by assuming that
partial specific volumes for the protein–RNA complexes are a
weighted average of their protein and RNA components.
We determined the mass of the bimolecular bI3 maturase–
L8 RNA complex by using an excess of (weakly absorbing)
maturase to be 220  12 kDa (Table 1). This value is consistent
with formation of a 1:1 maturase–RNA complex (calculated
mass  233 kDa) and provides independent support for the
conclusion, described above, that the bI3 maturase recognizes
the bI3 RNA as a monomer.
To determine rigorously the stoichiometry of the Mrs1-bound
Fig. 3. Guanosine cofactor binding and protein assembly of the bI3 ribonu-
cleoprotein. (A) Kinetic determination of pG binding. KM for pG was measured
at pH 7.5 (open circles, left axis) and pH 6.5 (filled triangles, right axis). Curves
were fit to kobs  kcat(1  KM[pG]). (B) Equilibrium RNA binding by the bI3
maturase. (C) Stoichiometric binding by the bI3 RNA–bI3 maturase complex is
consistent with formation of a 1:1 maturase–RNA complex at 20 mM Mg2,
[bI3 RNA]  100 nM (KD). (D) Magnesium ion-dependent, cooperative
assembly of Mrs1 with the bI3 group I intron RNA. Mrs1 dimer binding to the
bI3 intron is strongly cooperative under optimal splicing conditions (circles, 20
mM Mg2). In the absence of Mg2, binding is noncooperative (triangles) and,
at 4 mM Mg2, transitional behavior is observed (diamonds). (E) Stoichiomet-
ric binding assay for the formation of the Mrs1–bI3 RNA complex at 0 mM
(triangles) and 20 mM (circles) Mg2; [bI3 RNA]  100 nM (K1/2).
Table 1. The bI3 holoribonucleoprotein and its component
masses determined by sedimentation equilibrium
RNA bI3 maturase Mrs1 Observed Mr, kDa* Calculated Mr, kDa
 191  12 198
 35  3 35
 92  4 90†
  220  12 233
  372  10 378‡
   420  10 413‡
*Error estimates are reported as standard deviations from three or more
independent data sets.
†Assuming Mrs1 (Mr  45 kDa) is a dimer.
‡Assuming two Mrs1 dimers bind the bI3 RNA.
Fig. 4. Macromolecular masses of (A) the bI3-L8 RNA and (B) the bI3-L8
RNA–Mrs1–bI3 maturase ternary complex determined by sedimentation equi-
librium. Sedimentation profiles were fit to the Lamm equation (36), assuming
a single species (A and B Lower). Partial specific volumes for the RNA alone and
ternary complex were calculated to be 0.537 and 0.642 gcm3 and samples
were spun at 6,500 and 5,000 rpm, respectively. A and B Upper show the (small,
random) fit residuals.








RNA species, we mixed Mrs1 with the bI3-L8 RNA at 6:1 and
8:1 molar ratios. Complexes formed at both protein–RNA ratios,
detected by the RNA absorbance at 260 nm, sediment to give an
average molecular mass of 372  10 kDa (Table 1). This value
is identical to the calculated mass for a (Mrs1)4–bI3 RNA
complex of 378 kDa. This observed molecular mass further
supports the conclusion drawn above: Mrs1 binds as two dimers
to the bI3 group I intron RNA.
To form the ternary complex, we incubated one equivalent of
the bI3 maturase and five equivalents of Mrs1 with the bI3 intron
RNA. The radial absorbance profile was fit to a model for a
single ideal species and gave a molecular mass of 420  10 kDa
(Fig. 4B; Table 1). The molecular mass determined by sedimen-
tation equilibrium is in outstanding agreement with the calcu-
lated mass for this complex (413 kDa; Table 1). The bI3
holoribonucleoprotein comprises the bI3 RNA, a maturase
monomer, and two Mrs1 dimers.
Both the bI3 Maturase and Mrs1 Have Lost Functions Characteristic of
Their Close Homologs. ORFs for LAGLIDADG site-specific en-
donucleases, homologous with the bI3 maturase, appear to have
colonized group I introns on multiple occasions (23, 24). Using
oligodeoxynucleotide duplexes spanning 45 nt at the cyt b exon
3–exon 4 junction, we attempted to detect latent DNA endo-
nuclease activity under conditions that yield efficient cleavage in
other systems (16, 23). We failed to detect specific cleavage for
duplexes radiolabeled at either the coding or noncoding strands,
in the presence of Mg2 or Mn2, or at high concentrations of
bI3 maturase (data not shown). After 5 h, we did observe a low
(1%) level of cleavage, but this activity was observed for both
duplex and single-stranded DNAs and was not specific for the
correct junction sequence.
Mrs1 is homologous to the S. cerevisiae Cce1 protein (27, 28,
30). Under conditions where Cce1 efficiently cleaves DNA
junctions (27), we were unable to detect Holliday junction
cleavage with either migrating or fixed DNA junctions (data not
shown). Thus, both the bI3 maturase and Mrs1 appear to have
lost or are severely compromised in the DNA cleavage activity
of their structural homologs.
Discussion
Assembly of the bI3 Group I Intron Ribonucleoprotein. Our mecha-
nism for assembly and splicing by the bI3 ribonucleoprotein is
outlined in Fig. 5. Self-splicing by the bI3 intron is undetectable,
suggesting that the RNA does not achieve a catalytically active
conformation in the absence of protein cofactors. The bI3 maturase
and Mrs1 proteins bind independently to the RNA and with distinct
modes of assembly. The maturase binds as a monomer, whereas two
Mrs1 dimers assemble with strong cooperativity on the bI3 RNA.
The ternary complex has a molecular mass of 420 kDa and binds
the guanosine nucleophile with a KD of 0.2 mM. The active
ribonucleoprotein quaternary complex splices with a kcat of 0.3
min1. The reaction is particularly efficient, in that nearly all of the
cleaved 5 exon is converted to ligated exon product. Guanosine
attack at the 5 exon is the rate-determining step for the overall
splicing reaction.
Evolution in Splicing of the bI3 Group I Intron. Detectable splicing by
the bI3 intron depends on two protein facilitators in vitro, and the
evolutionary origin of each protein is distinct. Moreover, both
the bI3 maturase and Mrs1 appear to have lost or to be
compromised in the DNA nuclease-based functions that char-
acterize their closest homologs.
Proteins containing LAGLIDADG motifs are derived from a
family of DNA endonucleases, whose ORFs appear to have invaded
group I introns on multiple occasions (22–24). A subset of LA-
GLIDADG proteins additionally function as RNA maturases; this
RNA binding and splicing facilitation activity is thought to have
evolved from the existing DNA-binding function (Fig. 6A) (16, 22,
39). The maturase domain (Fig. 1B), which functions as a splicing
cofactor, is translated entirely from the intron RNA itself (Figs. 1
and 2A), similar to the I-AniI (16) and bI4 (40) maturases. Thus,
the functional portion of the bI3 maturase has had the opportunity
to coevolve with the bI3 intron.
Several lines of evidence suggest that the maturase has lost its
original DNA endonuclease activity. First, DNA endonuclease
activity is a prerequisite for intron mobility, and the bI3 intron
does not home into intronless genomes (41). Second, despite
significant effort, we do not detect cleavage of cyt b exon 3–exon
4 DNA junctions by purified bI3 maturase. Finally, structural
Fig. 6. Evolutionary series for the bI3 maturase (A) and Mrs1 (B). Activities
associated with each protein or class of proteins are emphasized at the left.
Branched arrows indicate there exist other outcomes (not shown) at each step
of diversification.
Fig. 5. Assembly of the bI3 ribonucleoprotein catalyst comprised of the bI3 RNA, bI3 maturase, Mrs1, and the guanosine nucleotide.
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analysis of related DNA binding proteins indicates that two
LAGLIDADG motifs form an interface consisting of parallel
-helices and bind Mg2 at their carboxyl termini (42–44). The
second aspartyl residue (underlined) in the motif is essential for
catalysis (45) and coordinates directly a catalytic Mg2 ion (43)
in homologous endonucleases. This residue is a structurally
nonconservative lysyl residue in the C-terminal motif (P2) in the
bI3 maturase (Fig. 1B, strain 777–3A). A plausible evolutionary
series for the bI3 maturase is shown in Fig. 6A.
The closest homolog to Mrs1 in the current databases is the S.
cerevisiae DNA junction-resolving enzyme Cce1. Cce1 is a member
of the RNase H fold superfamily of dimeric resolving enzymes,
which share a set of four conserved sequence motifs despite having
low sequence similarity overall (Fig. 6B) (29, 30). These four motifs
correspond to residues at the active site as visualized in the structure
of one member of this family, RuvC (29, 30).
Although Mrs1 shares a much higher level of sequence identity
with Cce1 than with any of the resolving enzymes, regions
conserved between Cce1 and Mrs1 do not correspond to the
regions most highly conserved among the DNA resolving en-
zymes. Motif 1 (29, 30) is missing altogether, and the other motifs
are less strongly conserved than in the highly divergent resolving
enzymes that make up the RNase H fold superfamily. Con-
versely, sequences strongly conserved between Cce1 and Mrs1
correspond to regions not conserved among the resolving en-
zymes. The likely explanation for these observations is that the
resolving enzymes have retained essential catalytic residues over
a very long period of evolutionary divergence because of their
conserved function. In contrast, Cce1 and Mrs1 have diverged
relatively recently, consistent with the phylogenetic restriction of
Mrs1 to the genus Saccharomyces and thus have a higher overall
sequence identity. The poor conservation of important catalytic
residues in Mrs1, the lack of detectable junction-resolving ac-
tivity (see above), and the observation that Mrs1 functions as a
dimer of dimers (Fig. 3D; Table 1) all emphasize that Mrs1 has
evolved to fulfill a new role in the cell (Fig. 6B).
Group I Introns as Tools for Understanding the Pervasiveness of
Ribonucleoproteins. The evolution and present day dispersal of
group I introns is complex and likely reflects both the retention
of some ancient introns and also significant horizontal transfer
of introns (reviewed in refs. 9, 21, and 22). However, no matter
what their evolutionary origin, analysis of intron encoded matu-
rase activities and the co-opting of other cellular proteins to
function as group I intron splicing cofactors provides an authen-
tic opportunity to evaluate the specific mechanistic and struc-
tural advantages and opportunism in evolving from an RNA
catalyst to an obligatory ribonucleoprotein. There are diverse
evolutionary series (Fig. 6) by which once RNA-based reactions
have become protein dependent, a frequent occurrence in the
transition from any RNA world to modern metabolism. Princi-
ples derived from the assembly and splicing of the bI3 group I
intron (Fig. 5) and from studies in comparative ribonucleopro-
tein assembly and catalysis (46) are likely to inform evolution of
other ribonucleoprotein complexes, especially cases where
RNA-centered functions have been enhanced or obscured by the
accumulation of multiple protein cofactors.
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